CD8A and neoplasm: Moreover, incorporating ropivacaine into the PFC for chemotherapy upregulated MHC-I expression in tumor cells and promoted their recognition by cytotoxic T lymphocytes (CD8+ T cells), thereby potentiating chemotherapy efficacy.